부산대학교 도서관

Kittane S; Johns Hopkins University Baltimore United States.; Ladewig E; Memorial Sloan Kettering Cancer Center New York, NY United States.; Li T; Johns Hopkins Medicine Baltimore United States.; Love JR; École Polytechnique Fédérale de Lausanne Lausanne Switzerland.; Blawski R; Johns Hopkins Medicine United States.; Gao Y; Johns Hopkins University United States.; Arruabarrena-Aristorena A; University of the Basque Country Leioa, Vizcaya Spain.; Zhao P; VIB-KU Leuven Center for Cancer Biology Leuven Belgium.; Dalrymple SL; Johns Hopkins University Baltimore, MD United States.; Liu H; AstraZeneca (United States) United States.; Guo X; Johns Hopkins Bloomberg School of Public Health Baltimore, MD United States.; Sallaku M; Memorial Sloan Kettering Cancer Center United States.; Kelkar N; Johns Hopkins Medicine United States.; Garcia-Martinez L; University of Miami Miller School of Medicine Miami United States.; Carmona Sanz J; Vall d'Hebron Institute of Oncology United States.; Chen W; Johns Hopkins University United States.; Stoudmann C; Formation Continue UNIL-EPFL Switzerland.; Baldino L; Memorial Sloan Kettering Cancer Center New York, NY United States.; Razavi-Mohseni M; Johns Hopkins University Baltimore, MD United States.; Kalemi I; Johns Hopkins Medicine United States.; Beer MA; Johns Hopkins University Baltimore United States.; Castel P; NYU Langone's Laura and Isaac Perlmutter Cancer Center New York United States.; Brennen WN; Johns Hopkins Medicine Baltimore, MD United States.; Scaltriti M; AstraZeneca (United States) New York, NY United States.; Morey L; University of Miami Miller School of Medicine Miami United States.; Cocco E; University of Miami Hospital United States.; Ji H; Johns Hopkins Bloomberg School of Public Health Baltimore, MD United States.; Chan HM; AstraZeneca (United States) United States.; Battle A; Johns Hopkins University United States.; Leslie CS; Memorial Sloan Kettering Cancer Center New York, NY United States.; Karthaus WR; Swiss Institute for Experimental Cancer Research (ISREC) Lausanne Switzerland.; Toska E; Johns Hopkins University Baltimore United States.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

Blawski R; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21231, USA.; Vokshi BH; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21231, USA.; Guo X; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.; Kittane S; Department of Biochemistry and Molecular Biology, Johns Hopkins School of Public Health, Baltimore, MD 21205, USA.; Sallaku M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Chen W; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.; Gjyzari M; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21231, USA.; Cheung T; AstraZeneca, Waltham, MA 02451, USA.; Zhang Y; Department of Biochemistry and Molecular Biology, Johns Hopkins School of Public Health, Baltimore, MD 21205, USA.; Simpkins C; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21231, USA.; Zhou W; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.; Kulick A; Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Zhao P; Department of Oncology, KU Leuven, 3000 Leuven, Belgium.; Wei M; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.; Shivashankar P; Department of Biochemistry and Molecular Biology, Johns Hopkins School of Public Health, Baltimore, MD 21205, USA.; Prioleau T; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21231, USA.; Razavi P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Koche R; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Rebecca VW; Department of Biochemistry and Molecular Biology, Johns Hopkins School of Public Health, Baltimore, MD 21205, USA.; de Stanchina E; Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Castel P; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY 10016, USA.; Chan HM; AstraZeneca, Waltham, MA 02451, USA.; Scaltriti M; AstraZeneca, Gaithersburg, MD 20878, USA.; Cocco E; Department of Biochemistry and Molecular Biology, University of Miami, Miller School of Medicine, Miami, FL 33136, USA.; Ji H; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.; Luo M; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Toska E; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21231, USA; Department of Biochemistry and Molecular Biology, Johns Hopkins School of Public Health, Baltimore, MD 21205, USA. Electronic address: etoska1@jhmi.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

Blawski, R.; Toska, E.

In: Current Breast Cancer Reports. (Current Breast Cancer Reports, December 2025, 17(1))

Blawski R; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.; Toska E; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.; Department of Biochemistry and Molecular Biology, Johns Hopkins School of Public Health, Baltimore, Maryland.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

Ladewig E; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Michelini F; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Jhaveri K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Castel P; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, New York.; Carmona J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Fairchild L; Weill Cornell Medical College, New York, New York.; Tri-Institutional Training Program in Computational Biology and Medicine, Weill Cornell Medical College, New York, New York.; Zuniga AG; Sidney Kimmel Comprehensive Cancer Center and Department of Oncology, Baltimore, Maryland.; Arruabarrena-Aristorena A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain.; Ikerbasque, Basque Foundation for Science, Bilbao, Spain.; Translational prostate cancer Research lab, CIC bioGUNE-Basurto, Biocruces Bizkaia Health Research Institute, Derio, Spain.; Cocco E; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Biochemistry and Molecular Biology, University of Miami, Miller School of Medicine, Miami, Florida.; Blawski R; Sidney Kimmel Comprehensive Cancer Center and Department of Oncology, Baltimore, Maryland.; Kittane S; Department of Biochemistry and Molecular Biology, Johns Hopkins School of Public Health, Baltimore, Maryland.; Zhang Y; Department of Biochemistry and Molecular Biology, Johns Hopkins School of Public Health, Baltimore, Maryland.; Sallaku M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Baldino L; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Hristidis V; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Chandarlapaty S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, New York.; Abdel-Wahab O; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Leslie C; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Scaltriti M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.; Toska E; Sidney Kimmel Comprehensive Cancer Center and Department of Oncology, Baltimore, Maryland.; Department of Biochemistry and Molecular Biology, Johns Hopkins School of Public Health, Baltimore, Maryland.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

Nardone A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Qiu X; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Spisak S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary.; Nagy Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Feiglin A; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.; Feit A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cohen Feit G; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Xie Y; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Font-Tello A; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Guarducci C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Hermida-Prado F; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Syamala S; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lim K; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Munoz Gomez M; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Pun M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cornwell M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Liu W; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ors A; Knight Cancer Early Detection Advanced Research Center, Oregon Health and Science University, Portland, Oregon.; Mohammed H; Knight Cancer Early Detection Advanced Research Center, Oregon Health and Science University, Portland, Oregon.; Cejas P; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Brock JB; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Winer EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Fu X; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Schiff R; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Long HW; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Metzger Filho O; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Jeselsohn R; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE